DK446389D0 - Cyclohexapeptid, praeparat indeholdende en saadan forbindelse og anvendelse af cyclohexapeptid - Google Patents

Cyclohexapeptid, praeparat indeholdende en saadan forbindelse og anvendelse af cyclohexapeptid

Info

Publication number
DK446389D0
DK446389D0 DK446389A DK446389A DK446389D0 DK 446389 D0 DK446389 D0 DK 446389D0 DK 446389 A DK446389 A DK 446389A DK 446389 A DK446389 A DK 446389A DK 446389 D0 DK446389 D0 DK 446389D0
Authority
DK
Denmark
Prior art keywords
cyclohexapeptide
connection
preparation containing
preparation
Prior art date
Application number
DK446389A
Other languages
English (en)
Other versions
DK446389A (da
DK173802B1 (da
Inventor
Dennis M Schmatz
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK446389D0 publication Critical patent/DK446389D0/da
Publication of DK446389A publication Critical patent/DK446389A/da
Application granted granted Critical
Publication of DK173802B1 publication Critical patent/DK173802B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198904463A 1988-09-12 1989-09-11 Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner DK173802B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US24276788A 1988-09-12 1988-09-12
US24276788 1988-09-12
US24604288A 1988-09-16 1988-09-16
US24604288 1988-09-16
US39888989A 1989-08-30 1989-08-30
US39888989 1989-08-30

Publications (3)

Publication Number Publication Date
DK446389D0 true DK446389D0 (da) 1989-09-11
DK446389A DK446389A (da) 1990-03-13
DK173802B1 DK173802B1 (da) 2001-11-05

Family

ID=27399603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198904463A DK173802B1 (da) 1988-09-12 1989-09-11 Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner

Country Status (7)

Country Link
EP (1) EP0359529B1 (da)
JP (1) JPH0725692B2 (da)
CA (1) CA1333150C (da)
DE (1) DE68905119T2 (da)
DK (1) DK173802B1 (da)
ES (1) ES2054017T3 (da)
IE (1) IE892924L (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020063A1 (en) * 1989-06-30 1990-12-31 Robert A. Giacobbe Antibiotic agent
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
FI912873A (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
US5366880A (en) * 1990-12-19 1994-11-22 Merck & Co., Inc. Antibiotic agent
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
TW199162B (da) * 1991-05-09 1993-02-01 Fujisawa Pharmaceutical Co
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
ATE140460T1 (de) * 1991-10-17 1996-08-15 Merck & Co Inc Echinocandin-b-derivat
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
GB9506372D0 (en) * 1995-03-29 1995-05-17 Fujisawa Pharmaceutical Co New peptide compounds
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
AU765660B2 (en) 1998-08-20 2003-09-25 Eli Lilly And Company Ring modified cyclic peptide analogs
BR9916101A (pt) 1998-12-09 2002-06-04 Lilly Co Eli Purificação de compostos de ciclopeptìdeos equinocandinos
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
CA2362016A1 (en) 1999-03-03 2000-09-08 Kenneth Philip Moder Echinocandin/carbohydrate complexes
EP1582204B1 (en) 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
KR20010112302A (ko) 1999-03-03 2001-12-20 피터 지. 스트링거 제약학적 경구용 ecb 조제물 및 조성물의 제조 방법
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803581A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Derivate des tetrahydro-echinocandin b
CA1183127A (en) * 1979-12-13 1985-02-26 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
EP0311193B1 (en) * 1987-10-07 1993-12-01 Merck & Co. Inc. Antifungal fermentation product
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product

Also Published As

Publication number Publication date
DK446389A (da) 1990-03-13
ES2054017T3 (es) 1994-08-01
EP0359529A1 (en) 1990-03-21
DE68905119T2 (de) 1993-08-26
IE892924L (en) 1990-03-12
JPH0725692B2 (ja) 1995-03-22
JPH02288837A (ja) 1990-11-28
EP0359529B1 (en) 1993-03-03
CA1333150C (en) 1994-11-22
DE68905119D1 (de) 1993-04-08
DK173802B1 (da) 2001-11-05

Similar Documents

Publication Publication Date Title
DK446389A (da) Cyclohexapeptid, praeparat indeholdende en saadan forbindelse og anvendelse af cyclohexapeptid
DK80591D0 (da) Retningsboreapparat og fremgangsmaade
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
ATA129389A (de) Zwei-phasen-knochenzement
DK211689D0 (da) Fluoravermectin- og -milbemycinforbindelser og praeparat indeholdende en saadan forbindelse
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289D0 (da) Piperazindioner, deres fremstilling og anvendelse
NO171591C (no) Forbindelse, biocid blanding og anvendelse
DK246189A (da) Antimikrobielt praeparat og anvendelse deraf
DK225089D0 (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK564189D0 (da) Insecticidt praeparat og insecticid aerosol
DK191787D0 (da) Carbapenemforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK451786A (da) Transglucosidase, fremstilling og anvendelse deraf
DK501989D0 (da) Mikrobiocidt praeparat og dettes fremstilling
DK641289D0 (da) Ophthalmologisk praeparat indeholdende et angiotensin-konverterende anzym og carboanhydrase
DK703588A (da) Pai-1-blokerende peptider, deres fremstilling og anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
NO892676L (no) Sialinsyre-bundet oktapeptid og fremstilling derav.
DK674587A (da) Anti-forkoelelses-kit, anti-forkoelelsespraeparat og anvendelse deraf
NO873029D0 (no) Metylenpreparat og anvendelse derav.
DK410089A (da) Substituerede phenylalkylthiophener og dens fremstilling
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
DK455189A (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
NO904846D0 (no) Amfifile peptider og anvendelse derav.
DK125786D0 (da) Peptider og fremstilling deraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK